Publicaciones (36) Publicaciones de MARIA DEL MAR ESTEBAN ORTEGA

2024

  1. An Observational Study in the Real Clinical Practice of the Treatment of Noninfectious Uveitis

    Journal of Clinical Medicine, Vol. 13, Núm. 5

  2. Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: UVEDAI©

    Ophthalmology and Therapy

2023

  1. AB1352 Impact of Systemic Therapies on the Seroprevalence of Sars-Cov-2 in Patients with Immune-Mediated Diseases

    Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1907.1-1907

  2. AB1470 Janus Kinase Inhibitors in Severe Inflammatory Ocular Pathology. Multicenter Study and Literature Review

    Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1963.2-1964

  3. Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)

    Ophthalmology and Therapy

  4. POS0652 Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: Uvedai

    Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 604-605

  5. POS0793-HPR Observational Study in Real Clinical Practice of the Treatment of Non-Infectious Uveitis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 689.2-690

  6. Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis

    Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 1045-1055

2022

  1. Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs—Findings From the BIOCOVID Study

    JCR: Journal of Clinical Rheumatology, Vol. 28, Núm. 2, pp. e348-e352

  2. Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients

    Clinical and Experimental Rheumatology

  3. Ocular inflammatory events following COVID-19 vaccination: a multinational case series

    Journal of Ophthalmic Inflammation and Infection, Vol. 12, Núm. 1

2021

  1. AB0396 Rapid Improvement in Cystoid Macular Edema With High Dose Intravenous Methylprednisolone in Non-Infectious Uveitis ff Different Immune Mediated Inflammatory Diseases

    Annals of the Rheumatic Diseases, Vol. 80, Núm. Suppl 1, pp. 1225.3-1226

  2. AB0771 High Dose Intravenous Methylprednisolone Induces Rapid Improvement of Visual Acuity in Non-Infectious Uveitis of Different Immune Mediated Inflammatory Diseases

    Annals of the Rheumatic Diseases, Vol. 80, Núm. Suppl 1, pp. 1412.1-1412

  3. Clinical Characteristics, Frailty, and Mortality of Residents With COVID-19 in Nursing Homes of a Region of Madrid

    Journal of the American Medical Directors Association, Vol. 22, Núm. 2, pp. 245-252.e2

  4. Inflammatory Relapses after Immunosuppressive Drug Discontinuation in Uveitis Patients: A Survival Analysis

    Ocular Immunology and Inflammation, Vol. 29, Núm. 2, pp. 376-387

  5. Measuring Choroid Thickness as a Marker of Systemic Inflammation in Patients with Ankylosing Spondylitis

    Journal of Clinical Rheumatology, Vol. 27, Núm. 8, pp. E307-E311

2020

  1. AB0726 Choroidal Thickness Is a Biomarker a and Can Predict The Response to Treatment in Ankylosing Spondylitis

    Annals of the Rheumatic Diseases, Vol. 79, Núm. Suppl 1, pp. 1657.1-1658

  2. Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis

    JCR: Journal of Clinical Rheumatology

  3. Reproducibilidad de la medición manual del grosor coroideo utilizando la tomografía de coherencia óptica

    Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 8, pp. 379-385

2019

  1. Choroidal and retinal thickness in systemic autoimmune and inflammatory diseases: A review

    Survey of Ophthalmology, Vol. 64, Núm. 6, pp. 757-769